TIM-3: a crucial regulator of NK cells in pregnancy

PrabhuDas M, Bonney E, Caron K, Dey S, Erlebacher A, Fazleabas A et al. Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol 2015; 16: 328–334.

Winger EE, Reed JL . The multiple faces of the decidual natural killer cell. Am J Reprod Immunol 2013; 70: 1–9.

Das M, Zhu C, Kuchroo VK . Tim-3 and its role in regulating anti-tumor immunity. Immunol Rev 2017; 276: 97–111.

Sakuishi K, Jayaraman P, Behar SM, Anderson AC, Kuchroo VK . Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2011; 32: 345–349.

Li YH, Zhou WH, Tao Y, Wang SC, Jiang YL, Zhang D et al. The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy. Cell Mol Immunol 2016; 13: 73–81.

Seo H, Jeon I, Kim BS, Park M, Bae EA, Song B et al. IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours. Nat Commun 2017; 8: 15776.

Gallois A, Silva I, Osman I, Bhardwaj N . Reversal of natural killer cell exhaustion by TIM-3 blockade. Oncoimmunology 2014; 3: e946365.

Da SI, Gallois A, Jimenez-Baranda S, Khan S, Anderson AC, Kuchroo VK et al. Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade. Cancer Immunol Res 2014; 2: 410–422.

Kwak-Kim J, Bao S, Lee SK, Kim JW, Gilman-Sachs A . Immunological modes of pregnancy loss: inflammation, immune effectors, and stress. Am J Reprod Immunol 2014; 72: 129–140.

Wang F, Hou H, Xu L, Jane M, Peng J, Lu Y et al. Tim-3 signaling pathway as a novel negative mediator in lipopolysaccharide-induced endotoxic shock. Hum Immunol 2014; 75: 470–478.

Hou H, Liu W, Wu S, Lu Y, Peng J, Zhu Y et al. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock. PLoS One 2014; 9: e110585.

Ndhlovu LC, Lopez-Verges S, Barbour JD, Jones RB, Jha AR, Long BR et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012; 119: 3734–3743.

Tao Y, Li YH, Piao HL, Zhou WJ, Zhang D, Fu Q et al. CD56(bright)CD25+ NK cells are preferentially recruited to the maternal/fetal interface in early human pregnancy. Cell Mol Immunol 2015; 12: 77–86.

Vong QP, Leung WH, Houston J, Li Y, Rooney B, Holladay M et al. TOX2 regulates human natural killer cell development by controlling T-BET expression. Blood 2014; 124: 3905–3913.

Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010; 52: 322–329.

Golden-Mason L, Waasdorp HC, Cheng L, Rosen HR . Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3. Clin Immunol 2015; 158: 114–125.

Lima JF, Oliveira LM, Pereira NZ, Duarte AJ, Sato MN . Polyfunctional natural killer cells with a low activation profile in response to Toll-like receptor 3 activation in HIV-1-exposed seronegative subjects. Sci Rep 2017; 7: 524.